PA28 γ Antibodies

Santa Cruz Biotechnology offers a broad range of PA28 γ monoclonal antibodies for research applications. PA28 γ monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PA28 γ, also known as proteasome activator complex, plays a crucial role in the regulation of the proteasome, enhancing its ability to degrade ubiquitinated proteins. PA28 γ maintains cellular homeostasis and participates in various cellular processes, including antigen processing and presentation, which are vital for immune response. Understanding PA28 γ function is important for elucidating mechanisms of disease and developing therapeutic strategies. PA28 γ monoclonal antibodies enable precise detection and characterization of protein expression patterns across different cell types and tissues. PA28 γ monoclonal antibodies support investigation of proteasome regulation and protein degradation pathways. Santa Cruz Biotechnology monoclonal antibodies contribute to advancing scientific understanding of cellular processes and disease mechanisms.